18F-CP18
N/A
Report date: 2022/05/23 17:24:51
NME
Base Information
Drug Name18F-CP18
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health Clinical Center (Cc)
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A